Financials

News Discussions Technicals Forecast Seasonals

2096 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SIMCERE PHARMACEUTICAL GRP LTD operating, investing, and financing activities

2096 free cash flow for H2 24 is 271.15 M HKD. For 2024, 2096 free cash flow was 1.21 B HKD and operating cash flow was 1.59 B HKD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—